Tradestie Institutional Equity Comparison Engine

ANNX vs ENTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTA Overall Edge

ENTA Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enanta Pharmaceuticals, Inc (ENTA) driven by superior Valuation, Options & Structure while ANNX counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, ANNX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENTA at 44.0x Forward P/E and -90.0% operating margin (-21.6% YoY). In options structure, ANNX sits in BREAKDOWN (40th %ile IV; Dealer Gamma Walls on Pro) against ENTA sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENTA
ANNX N/M vs ENTA 44.0x Fwd P/E
Growth & Margin Winner ANNX
Op Margin 0.0% vs -90.0% ยท YoY +0.0% vs -21.6%
Momentum & Technical Winner ANNX
1Y +35.3% vs -7.9% ยท 52W Pos 23% vs 10%
Options & Structure Winner ENTA
BREAKDOWN (40th %ile IV) vs BREAKDOWN (11th %ile IV)
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.62
-7.53% 1D
Market Cap $757.3M
1M Return +6.3%
1Y Return +35.26%
Forward P/E N/M
Unified AI Score
44.6 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 68.0 Mom 60.0
ENTA NASDAQ
Enanta Pharmaceuticals, Inc
Pharmaceutical Preparations
$10.79
-1.82% 1D
Market Cap $326.2M
1M Return -2.79%
1Y Return -7.94%
Forward P/E 44.0x
Unified AI Score
46.2 / 100 HOLD
Tech 53.0 Fund 54.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANNX +35.26% ENTA -7.94% Spread: +43.2 pp (ANNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANNX TTM Op. Margin: 0.0% ENTA TTM Op. Margin: -90.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANNX vs ENTA. Trailing 12-month operating profitability (ANNX 0.0% vs ENTA -90.0%) and valuation multiples (ANNX N/M vs ENTA 44.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANNX (5) vs ENTA (5)
Institutional Metric ANNX ENTA Criterion Row Winner
Market Capitalization Scale $757.3M $326.2M Larger Scale ANNX
Trailing P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Forward P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Revenue Growth (YoY) Growth +0.0% -21.6% Higher Growth ANNX
Operating Margin (TTM) Profitability 0.0% -90.0% Higher Margin ANNX
Net Profit Margin Profitability 0.0% -96.9% Higher Margin ANNX
Return on Equity (ROE) Capital Efficiency -130.8% -70.1% Higher ROE ENTA
52-Week Range Position Momentum 23% ($3โ€“$7) 10% ($10โ€“$17) Stronger Trend ANNX
Beta / 30D Volatility Risk Regime 1.69ฮฒ ยท 64% Vol 0.89ฮฒ ยท 58% Vol Lower Realized Risk ENTA
Unified Institutional Score Composite Signal 44.6 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite ENTA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANNX vs ENTA Buy Guide
ANNX BREAKDOWN
87d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 40th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTA BREAKDOWN
95d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live ENTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANNX nor ENTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.